Emsam and Visual acuity reduced - a phase IV clinical study of FDA data

Summary:

Visual acuity reduced is reported only by a few people who take Emsam.

The phase IV clinical study analyzes which people take Emsam and have Visual acuity reduced. It is created by eHealthMe based on reports of 1,591 people who have side effects while taking Emsam from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 20, 2023

1,591 people reported to have side effects when taking Emsam.
Among them, 2 people (0.13%) have Visual acuity reduced.

What is Emsam?

Emsam has active ingredients of selegiline. It is often used in depression. eHealthMe is studying from 1,815 Emsam users for its effectiveness, alternative drugs and more.

What is Visual acuity reduced?

Visual acuity reduced (reduced clearness of vision) is found to be associated with 2,421 drugs and 1,852 conditions by eHealthMe.

Number of Emsam and Visual acuity reduced reports submitted per year:

Could Emsam cause Visual acuity reduced?

Gender of people who have Visual acuity reduced when taking Emsam *:

female: 100 %
male: 0.0 %

Common drugs people take besides Emsam *:

Zetia: 1 person, 50.00%
Synthroid: 1 person, 50.00%
Motrin: 1 person, 50.00%
Geodon: 1 person, 50.00%

Common side effects people have besides Visual acuity reduced *:

Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 50.00%
Pruritus Generalised (generalized itching): 1 person, 50.00%
Migraine (headache): 1 person, 50.00%
Insomnia (sleeplessness): 1 person, 50.00%
Generalised Erythema (redness of the skin all over the body): 1 person, 50.00%
Fear: 1 person, 50.00%
Diplopia (double vision): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Emsam and have Visual acuity reduced?

Check whether Visual acuity reduced is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Visual acuity reduced and when was it recovered:

Visual acuity reduced in Emsam

Expand to all the drugs that have ingredients of selegiline:

Visual acuity reduced and drugs with ingredients of selegiline

Alternative drugs to, pros and cons of Emsam:

Emsam (1,815 reports)

Common Emsam side effects:

Drug ineffective: 188 reports
Insomnia (sleeplessness): 147 reports
Depression: 121 reports
Stress and anxiety: 102 reports

Browse all side effects of Emsam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Visual acuity reduced treatments and more:

Visual acuity reduced (43,517 reports)

COVID vaccines that are related to Visual acuity reduced:

Common drugs associated with Visual acuity reduced:

All the drugs that are associated with Visual acuity reduced:

Visual acuity reduced (2,421 drugs)

Common conditions associated with Visual acuity reduced:

Multiple sclerosis: 3,225 reports
Diabetes: 1,904 reports
Type 2 diabetes: 1,705 reports
High blood pressure: 1,609 reports

All the conditions that are associated with Visual acuity reduced:

Visual acuity reduced (1,852 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on selegiline (the active ingredients of Emsam) and Emsam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.